Hemerion
Hemerion is a treatment for brain cancer founded in 2020.
1
Funding Rounds
$2.2m
Money raised
Overview
Hemerion is a treatment for brain cancer founded in 2020.
-
Website:
- Headquarters: Marseille
- Social accounts:
Funding series
Funding Series Analysis
The company Hemerion has raised a total of $2.2m in funding over 1 rounds.
Key Insights:
- Hemerion April 2023 Seed Funding Round: $2.2m
Hemerion April 2023 Seed Funding Round
$2.2m